Bermingham Nessan 4
4 · Intellia Therapeutics, Inc. · Filed Dec 14, 2017
Insider Transaction Report
Form 4
Bermingham Nessan
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2017-12-12+292,500→ 292,500 totalExercise: $18.30Exp: 2027-12-11→ Common Stock (292,500 underlying)
Footnotes (1)
- [F1]This option was granted on December 12, 2017 with respect to 292,500 shares of Common Stock, with 25% vesting on December 12, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.